Pfizer, Inc. (PFE) is listed on NYSE in Pharmaceutical Stocks. It is $27.96, -0.23%, with a $159.3B market cap. RSI is 64.8, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 64.8 Near Overbought
Market Cap $159.3B
Volume 23.9M
Fundamentals — 10-Q Q2 2026
Revenue $29.5B
Net Income $2.4B
EPS $0.43
Gross Margin 74.1%
Net Margin 8.3%
Debt / Equity 0.7x
P/E Ratio 65.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Bourla Albert | Chairman & CEO | Buy | 38,000 | $26.34 | $1.0M | 2026 Aug 12 |
| Damico Jennifer B. | SVP & Controller | Sell | 3,278 | $25.40 | $83,261 | 2026 Aug 5 |
| Blaylock Ronald E | Director | Buy | 39,231 | $25.46 | $998,821 | 2026 Aug 5 |
| Buckley Mortimer J | Director | Buy | 37,632 | $25.52 | $960,369 | 2026 Aug 5 |
| Damico Jennifer B. | SVP & Controller | Sell | 2,000 | $25.70 | $51,400 | 2026 Jun 9 |
| Damico Jennifer B. | SVP & Controller | Sell | 2,500 | $25.93 | $64,825 | 2025 Mar 4 |
| Blaylock Ronald E | Director | Buy | 19,457 | $25.65 | $499,072 | 2025 Feb 13 |
| Gottlieb Scott | Director | Buy | 1,000 | $28.24 | $28,240 | 2024 Oct 30 |
| Damico Jennifer B. | SVP & Controller | Sell | 5,154 | $28.66 | $147,714 | 2024 Aug 13 |
| Gottlieb Scott | Director | Buy | 3,000 | $26.47 | $79,410 | 2023 Dec 15 |
| Gottlieb Scott | Director | Buy | 2,000 | $38.51 | $77,010 | 2023 May 8 |
| Damico Jennifer B. | SVP & Controller | Sell | 9,912 | $40.02 | $396,678 | 2023 Mar 15 |
| Damico Jennifer B. | SVP & Controller | Sell | 4,218 | $53.96 | $227,603 | 2022 Jun 7 |
| Damico Jennifer B. | SVP & Controller | Sell | 4,000 | $50.50 | $202,000 | 2022 May 16 |
| Sahni Payal | Executive Vice President | Sell | 1,408 | $49.84 | $70,175 | 2022 May 13 |
| Lankler Douglas M | Executive Vice President | Sell | 38,273 | $49.41 | $1.9M | 2022 May 12 |
| Carapezzi William R JR | Executive Vice President | Sell | 32,908 | $50.00 | $1.6M | 2022 May 12 |
| Dolsten Mikael | President R&D | Sell | 63,902 | $49.32 | $3.2M | 2022 May 11 |
| Johnson Rady A | Executive Vice President | Sell | 19,000 | $53.42 | $1.0M | 2021 Dec 3 |
| Mackenzie Alexander R | Executive Vice President | Sell | 41,360 | $54.26 | $2.2M | 2021 Dec 2 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $794.08 | 58.2 | $82.1B |
| | $112.44 | 58.9 | $195.8B |
| | $45.60 | 41.8 | -- |
| | $244.60 | 46.0 | $15.9B |
| | $541.72 | 61.7 | $137.3B |
Take PFE further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put PFE in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Pfizer, Inc. next reports.
Set alerts on PFE
Get notified when Pfizer, Inc. hits your price targets or technical conditions are met.
Get Started Free